Navigation Links
Bioglue in Medical News

CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology

...ich BioGlue((R)) Surgical Adhesive was developed. bioglue is approved by the U.S. Food and Drug Administrati...staples in open surgical repair of large vessels. bioglue is also CE marked in the European Community and ap...atients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and ap...

CryoLife Reports Record Quarterly Revenues of $28.2 Million

...t during the second quarter of 2008, which reduced bioglue revenues by $331,000 for the second quarter of 2009, bioglue revenues would have been $12.7 million. bioglue revenues were $24.1 million for the first six mont...

CryoLife Announces Release Date and Teleconference Call Details for 2009 Second Quarter Financial Results

...taples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. bioglue Aesthetic (TM) Medical Adhesive is CE marked in the European Community for...

BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates

... market in 1998 and in the United States in 2001. bioglue is a leading surgical adhesive used in cardiovascular surgeries worldwide. "I have been using bioglue since its market introduction almost 10 years ago,...ist Hospital, Indianapolis, Ind. "I have utilized bioglue in over 1,000 patients undergoing a variety of car...

Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology

...n adjunct to sutures and staples in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Aust...taples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Aust...

CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoL...

William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoL...
Bioglue in Medical Technology

Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...

CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a ...
Bioglue in Medical Products

Bioglue

Features:... The bioglue component has a shelf life of 3 years if stored at 25 C. bioglue also adheres to synthetic graft materials via mechanical interlocks within ...
Company:Cryolife, Inc.
Bioglue in Biological Technology

CryoLife Reports Record First Quarter Revenues of $26.7 Million

...ere was a 2 percent increase in the milliliters of bioglue shipped, revenues decreased 1 percent. Excluding ...exchange rates quarter over quarter, which reduced bioglue revenues by $306,000 in the first quarter of 2009, bioglue revenues would have been $12.1 million, or a 2 per...

CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008

...fourth quarter of 2007, an increase of 5 percent. bioglue revenues were $48.6 million for the year ended Dec...r 31, 2007, an increase of 11 percent. U.S. bioglue revenues were $8.6 million and $8.1 million for th...rth quarters of 2008 and 2007, respectively. U.S. bioglue revenues were $34.4 million and $31.6 million for ...

CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007

... third quarter of 2007, an increase of 13 percent. bioglue revenues were $36.5 million for the first nine mon... months of 2007, an increase of 13 percent. U.S. bioglue revenues were $8.1 million and $7.4 million in the...third quarter of 2008 and 2007, respectively. U.S. bioglue revenues were $25.8 million and $23.4 million in t...

CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2008 Financial Results

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...

CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...

CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc.

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...
Other Tags
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
Other Contents